pre-IPO PHARMA

COMPANY OVERVIEW

Centrexion Therapeutics is transforming the treatment of chronic pain by advancing one of the largest exclusively pain-focused pipelines of novel, non-opioid therapies. We are working to bridge the safety and efficacy gaps in current approaches to chronic pain management.


LOCATION

  • Boston, MA, USA

  • THERAPEUTIC AREAS

  • Pain

  • WEBSITE

    https://centrexion.com/


    CAREER WEBSITE

    None


    SOCIAL MEDIA


    INVESTORS



    PRESS RELEASES


    Oct 29, 2020

    Centrexion Therapeutics Raises $40.5 Million and Adds Lilly and Exome Asset Management as New Investors


    Oct 29, 2020

    Centrexion Therapeutics Raises $40.5 Million and Adds Lilly and Exome Asset Management as New Investors


    Dec 3, 2019

    Centrexion Therapeutics Announces Issuance of U.S. Composition of Matter Patent for Lead Pipeline Candidate CNTX-4975


    Dec 3, 2019

    Centrexion Therapeutics Announces Issuance of U.S. Composition of Matter Patent for Lead Pipeline Candidate CNTX-4975


    Nov 8, 2019

    Centrexion Therapeutics Announces CNTX-4975 Data Presentations at the 2019 American College of Rheumatology Annual Meeting and the 2019 American Academy of Physical Medicine and Rehabilitation Annual Assembly


    For More Press Releases


    Google Analytics Alternative